Abstract
Two patients with hemangioendothelioma and elevated plasma vascular endothelial growth factor (VEGF) levels are presented. A reduction in the plasma VEGF level after therapeutic intervention correlated with a successful clinical response. Conversely, a stable plasma VEGF level correlated with therapeutic failure.
MeSH terms
-
Biomarkers, Tumor / blood*
-
Hemangioendothelioma / blood*
-
Hemangioendothelioma / congenital
-
Hemangioendothelioma / surgery
-
Hepatectomy
-
Hip Contracture / etiology
-
Hip Contracture / pathology
-
Humans
-
Infant
-
Liver Neoplasms / blood*
-
Liver Neoplasms / congenital
-
Liver Neoplasms / surgery
-
Magnetic Resonance Imaging
-
Male
-
Neoplasm Proteins / blood*
-
Neoplasm Recurrence, Local / drug therapy
-
Prednisolone / therapeutic use
-
Soft Tissue Neoplasms / blood*
-
Soft Tissue Neoplasms / drug therapy
-
Soft Tissue Neoplasms / surgery
-
Subcutaneous Tissue
-
Vascular Endothelial Growth Factor A / blood*
Substances
-
Biomarkers, Tumor
-
Neoplasm Proteins
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Prednisolone